Multiple randomized trials prove more stroke patients can benefit from thrombectomy
Society of NeuroInterventional Surgery issues update to standards and guidelines following research in favor of minimally invasive procedure for deadly type of stroke
2024-06-05
(Press-News.org) FOR IMMEDIATE RELEASE: June 5, 2024
CONTACT: Faith James
fjames@vancomm.com or 202-248-5450
Multiple Randomized Trials Prove More Stroke Patients Can Benefit from Thrombectomy
Society of NeuroInterventional Surgery issues update to standards and guidelines following research in favor of minimally invasive procedure for deadly type of stroke
FAIRFAX, Va. — Access to thrombectomy should be expanded to include patients who experience basilar artery occlusion (BAO), a deadly type of emergent large vessel occlusion stroke, urges the Society of NeuroInterventional Surgery (SNIS). The scientific association, which represents more than 1,200 neurointerventionalists globally, issued an update to its standards and guidelines in the Journal of NeuroInterventional Surgery (JNIS), citing randomized trials proving endovascular thrombectomy (EVT) can be a lifesaving treatment for BAOs. Currently, 68% of patients with BAOs end up dying or having a lifetime of disability, making it one of the most dreaded types of stroke.
Through a structured literature review and analysis, “Focused update to guidelines for endovascular therapy for emergent large vessel occlusion: basilar artery occlusion patients” cites the results of two recent positive randomized EVT trials — ATTENTION (Endovascular Treatment for Acute Basilar Artery Occlusion) and BAOCHE (Basilar Artery Occlusion Chinese Endovascular Trial). Adult patients ages 18 to 89 who scored high on common stroke severity scales (meaning their symptoms were severe versus mild) had significantly lower rates of mortality at 90 days post treatment compared to those who were treated with medical therapy alone.
“These two new trials demonstrate without ambiguity that EVT is not only effective for adult BAO patients within 0–12 and 6–24 hours of symptom onset but proves far better patient outcomes compared to medical therapy,” said Steven Hetts, MD, SNIS Standards Committee Chair. “Considering the potentially devastating consequences of a BAO stroke, including death or locked-in syndrome, the impact of offering improved treatment options is of critical importance.”
The recommendations were made by consensus of the writing committee, with additional input from the full SNIS Standards and Guidelines Committee and the SNIS Board of Directors. Thrombectomy treatment of patients with a vertebral artery occlusion or BAO with mild symptoms should be based on individual situations that balance the risks and benefits of thrombectomy compared with medical therapy.
Mahesh Jayaraman, MD, Professor and Chair of Diagnostic Imaging at Brown University, Director of the Neurovascular Center at Rhode Island Hospital and President of SNIS, believes that the update to SNIS standards and guidelines will lead to more thrombectomy transfers to appropriate centers, and most importantly, a cumulative reduction in the degree of stroke disability and burden to patients and their loved ones.
“With each study that proves more patients can benefit from minimally invasive neurointerventional procedures, members of SNIS and the field are reminded of why they do the work they do,” said Dr. Jayaraman. “These findings further support the notion that no matter where they live or the type of stroke they experience, every patient deserves triage and transport to appropriate care so they are given a chance to survive and thrive.”
To speak with Drs. Hetts or Jayaraman about the updated SNIS standards and guidelines, please contact Faith James and fjames@vancomm.com or 202-248-5450.
About the Society of NeuroInterventional Surgery
The Society of NeuroInterventional Surgery (SNIS) is a scientific and educational association dedicated to advancing the specialty of neurointerventional surgery through research, standard-setting, and education and advocacy to provide the highest quality of patient care in diagnosing and treating diseases of the brain, spine, head and neck. Visit www.snisonline.org and follow us on X (@SNISinfo) and Facebook (@SNISOnline).
―30―
END
ELSE PRESS RELEASES FROM THIS DATE:
2024-06-05
June 5, 2024
Researchers Led by UMass Amherst Solve 2,000-Year-Old Mystery of the Shipworm
Secret of the world’s most destructive and intriguing mollusk has implications for everything from climate change to human health
AMHERST, Mass. – They bedeviled ancient Greek navies, helped shipwreck Christopher Columbus, aided in the sinking of the Spanish Armada and caused the wharves in San Francisco Bay to collapse into the sea, but until now, scientists have been unable to pinpoint exactly ...
2024-06-05
A short course of immunotherapy was found to be highly effective in a subset of patients with colon cancer. The treatment, which consisted of two cycles of immunotherapy prior to surgery, was effective in almost all patients. In two third of patients, there were no longer any live tumor cells at the time of surgery. The patients’ immune system had cleaned up the cancer cells. These groundbreaking discoveries were made as part of the NICHE-2 trial at the Netherlands Cancer Institute and have been published in the New England Journal of Medicine.
Patients with colon cancer with ...
2024-06-05
BIRMINGHAM, Ala. – Preliminary clinical data for glioblastoma multiforme patients enrolled in a Phase 1 clinical trial at the University of Alabama at Birmingham demonstrated that 92 percent of evaluable patients treated with INB-200 exceeded a median progression-free survival of seven months with concomitant temozolomide chemotherapy. The median follow-up was 11.7 months.
This survival data along with radiographic improvements are indicative of positive treatment effects, which highlights the potential of IN8bio’s genetically modified, chemotherapy-resistant gamma-delta T cells ...
2024-06-05
New Haven, Conn. — Negative early life experiences, such as attending segregated schools, contribute significantly to cognitive decline and cognition disparities between older Black and white Americans, according to a new study led by researchers at the Yale School of Public Health.
The study, published in JAMA Internal Medicine, is the first to look at the impact of school segregation upon later life cognition using a large representative sample of the U.S. population, said lead author Xi Chen, associate professor of public ...
2024-06-05
After an extensive national search, Jessica Snowden, MD, MS, FAAP, MHPTT, a nationally recognized pediatric infectious disease specialist and researcher, has been named the new vice chancellor for Research at the University of Tennessee Health Science Center, effective September 1. She will also serve as a professor in the College of Medicine in the Department of Pediatrics.
Currently the vice dean for Research and chief of Pediatric Infectious Diseases at the University of Arkansas for Medical Sciences (UAMS), Dr. Snowden is known as a dedicated mentor and a leader in integrating clinical, research, and academic efforts to advance the understanding ...
2024-06-05
“The results provide novel preclinical data that demonstrate synergism between HDACi- and PARPi-mediated inhibition of DNA repair and decitabine in pancreatic cancer [...]”
BUFFALO, NY- June 5, 2024 – A new research paper was published in Oncotarget's Volume 15 on June 3, 2024, entitled, “Synergistic cytotoxicity of histone deacetylase and poly-ADP ribose polymerase inhibitors and decitabine in pancreatic cancer cells: Implications for novel therapy.”
Histone deacetylase inhibitors (HDACi) can modulate the acetylation status of proteins, influencing the genomic instability exhibited by cancer cells. Poly (ADP ribose) ...
2024-06-05
Diabetes rates continue to rise, with 11.7 million Canadians living with diabetes or pre-diabetes. At UBC, scientists have created a pain-free drug delivery method to help people with diabetes manage the disease and maintain their health more easily.
Researchers at the Li Lab have developed oral insulin drops that when placed under the tongue are quickly and efficiently absorbed by the body, potentially replacing the need for insulin injections.
The drops contain a mixture of insulin and a unique cell-penetrating peptide (CPP) developed ...
2024-06-05
EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, JUNE 5, 2024
MINNEAPOLIS – A new study suggests that people who take a few common drugs may have a decreased risk of having a bleeding stroke due to a ruptured brain aneurysm. The study is published in the June 5, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. The results do not prove that these drugs reduce the risk of this type of aneurysm; they only show an association.
“We urgently need new ways to prevent this type of stroke, which occurs at younger ages and with a higher death rate than other types of stroke,” said study author Jos Peter Kanning, ...
2024-06-05
The Gerontological Society of America (GSA) has received renewed grant support to welcome a 15th class of reporters for the Journalists in Aging Fellows Program. The 2024 funders to date include Silver Century Foundation, The John A. Hartford Foundation, and National Institute for Health Care Management Foundation (NIHCM).
Since its founding in 2010, this program has been responsible for more than 800 news stories produced by 231 alumni. It has two goals: to educate journalists about issues in aging, better allowing them to spread a new awareness to general-audience, ethnic, and other minority populations; and to disseminate information about new scientific findings, ...
2024-06-05
Cyberattacks driven by Artificial Intelligence (AI) pose unprecedented risks to global economies, supply chains, and trade. A forthcoming study from the journal Risk Analysis explores the cascading impacts of AI-driven cyberattacks.
Unlike traditional cyberattacks, which are typically manual or scripted, AI-driven cyberattacks utilize AI and machine learning algorithms to enhance their effectiveness, stealthiness and adaptability. AI-driven cyberattacks can autonomously learn and evolve their tactics, techniques and procedures based on real-time feedback and environmental changes.
Through simulation scenarios, the researchers discovered the potential ...
LAST 30 PRESS RELEASES:
[Press-News.org] Multiple randomized trials prove more stroke patients can benefit from thrombectomy
Society of NeuroInterventional Surgery issues update to standards and guidelines following research in favor of minimally invasive procedure for deadly type of stroke
